Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research ...

Signs of Structural Damage in Homes Built Before 1990 and What to Do About ItHave you ever walked through your home and ...

The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and ...

You're deep in clinical research operations, and decentralized clinical trials software has become the go-to for handling ...

The "Gastrointestinal Diagnostics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Gastrointestinal Diagnostics was valued at US$4.9 ...

Rising Demand Driven by Shift to Outpatient CareThe global ambulatory surgical center (ASC) software market is expected to ...

The global hernia repair devices market is projected to grow at a steady CAGR of approximately 5–7% through 2027. Market ...

AI assisted Health Cube open to patients in Guardia Perticara (Basilicata), Italy VANCOUVER, BC / ACCESS Newswire / December ...

The "Constipation Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Constipation Treatment was valued at US$19.5 Billion in 2024 ...

Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. (“PRISM”) to accelerate the discovery and ...

The "Drug Discount Cards Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Drug Discount Cards was valued at US$14.9 Billion in 2024 ...

GSK’s Exdensur is approved by the US FDA as a twice-yearly add-on treatment for severe eosinophilic asthma in patients 12 and ...